Evidence map›Paper›PMID 37283715›Full record

ArticleInternational journal of nanomedicine2023

Multiple RNA Profiling Reveal Epigenetic Toxicity Effects of Oxidative Stress by Graphene Oxide Silver Nanoparticles in-vitro.

Yu-Guo Yuan, Ya-Xin Zhang, Song-Zi Liu, Abu Musa Md Talimur Reza, Jia-Lin Wang, Ling Li, He-Qing Cai, Ping Zhong, Il-Keun Kong

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Genomic Impacts of Biological Exposures.Journal of developmental biology · 2026
    Review
  2. Comprehensive analysis ofAnimal biotechnology · 2025
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Yu-Guo Yuan *College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Ya-Xin Zhang *College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Song-Zi Liu *College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Abu Musa Md Talimur RezaDepartment of Molecular Biology and Genetics Faculty of Basic Sciences, Gebze Technical University, Kocaeli, Republic of Turkiye.
Jia-Lin WangCollege of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Ling LiCollege of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
He-Qing CaiCollege of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Ping ZhongCollege of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Il-Keun KongDivision of Applied Life Science (BK21 Four), Institute of Agriculture and Life Science, Gyeongsang National University, Jinju, Gyeongnam Province, Republic of Korea.
Yangzhou University · CNGebze Technical University · TRGyeongsang National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The increasing industrial and biomedical utilization of graphene oxide silver nanoparticles (GO-AgNPs) raises the concern of nanosafety: exposure to the AgNPs or GO-AgNPs increases the generation of reactive oxygen species (ROS), causes DNA damage and alters the expression of whole transcriptome including mRNA, miRNA, tRNA, lncRNA, circRNA and others. Although the roles of different RNAs in epigenetic toxicity are being studied during the last decade, but still we have little knowledge about the role of circle RNAs (circRNAs) in epigenetic toxicity. Methods: Rabbit fetal fibroblast cells (RFFCs) were treated with 0, 8, 16, 24, 32 and 48 μg/mL GO-AgNPs to test the cell viability and 24 μg/mL GO-AgNPs was selected as the experimental dose. After 24 h treatment with 24 μg/mL GO-AgNPs, the level of ROS, malondialdehyde (MDA), superoxide dismutase (SOD), intracellular ATP, glutathione peroxidase (GPx), and glutathione reductase (Gr) were measured in the RFFCs. High-throughput whole transcriptome sequencing was performed to compare the expression of circRNAs, long non-coding RNAs (lncRNA) and mRNA between 24 μg/mL GO-AgNPs-treated RFFCs and control cells. Quantitative real-time polymerase chain reaction (qRT-PCR) analysis was performed to validate the accuracy of circRNA sequencing data. Bioinformatics analyses were performed to reveal the potential functional roles and related pathways of differentially expressed circRNAs, lncRNA and mRNA and to construct a circRNA-miRNA-mRNA interaction network. Results: We found that 57 circRNAs, 75 lncRNAs, and 444 mRNAs were upregulated while 35 circRNAs, 21 lncRNAs, and 186 mRNAs were downregulated. These differentially expressed genes are mainly involved in the transcriptional mis-regulation of cancer through several pathways: MAPK signaling pathway (circRNAs), non-homologous end-joining (lncRNAs), as well as PPAR and TGF-beta signaling pathways (mRNAs). Conclusion: These data revealed the potential roles of circRNAs in the GO-AgNPs induced toxicity through oxidative damage, which would be the basis for further research to determine their roles in the regulation of different biological processes.

Indexed as

Metal NanoparticlesMicroRNAsRNA, Long NoncodingAnimalsEpigenesis, GeneticGene Expression ProfilingGraphiteOxidative StressRabbitsReactive Oxygen SpeciesRNA, CircularRNA, MessengerSilvergraphene oxideGraphiteMicroRNAsReactive Oxygen SpeciesRNA, CircularRNA, Long NoncodingRNA, MessengerSilvercircRNAsepigenetic toxicityGO-AgNPsoxidative stress

Identifiers

PMID37283715
PMCPMC10239647
OpenAlexW4378903749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.